Literature DB >> 9436900

End-of-life care in HIV disease: let's talk.

I B Wilson.   

Abstract

Entities:  

Keywords:  Death and Euthanasia; Professional Patient Relationship

Mesh：

Year:  1997        PMID： 9436900      PMCID： PMC1497207          DOI： 10.1046/j.1525-1497.1997.07166.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  26 in total

1.  Impact of combination therapy for HIV infection on inpatient census.

Authors:  R A Torres; M Barr
Journal:  N Engl J Med       Date:  1997-05-22       Impact factor: 91.245

2.  Is experience a good teacher? How interns and attending physicians understand patients' choices for end-of-life care. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.

Authors:  I B Wilson; M L Green; L Goldman; J Tsevat; E F Cook; R S Phillips
Journal:  Med Decis Making       Date:  1997 Apr-Jun       Impact factor: 2.583

3.  Patient preferences for communication with physicians about end-of-life decisions. SUPPORT Investigators. Study to Understand Prognoses and Preference for Outcomes and Risks of Treatment.

Authors:  J C Hofmann; N S Wenger; R B Davis; J Teno; A F Connors; N Desbiens; J Lynn; R S Phillips
Journal:  Ann Intern Med       Date:  1997-07-01       Impact factor: 25.391

4.  Structured deliberation to improve decisionmaking for the seriously ill.

Authors:  L L Emanuel
Journal:  Hastings Cent Rep       Date:  1995 Nov-Dec       Impact factor: 2.683

5.  Once again, reality. Now where do we go?

Authors:  D Callahan
Journal:  Hastings Cent Rep       Date:  1995 Nov-Dec       Impact factor: 2.683

6.  The green eggs and ham phenomena.

Authors:  L Forrow
Journal:  Hastings Cent Rep       Date:  1994 Nov-Dec       Impact factor: 2.683

Review 7.  Can clinical interventions change care at the end of life?

Authors:  L C Hanson; J A Tulsky; M Danis
Journal:  Ann Intern Med       Date:  1997-03-01       Impact factor: 25.391

8.  A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group.

Authors:  S A Danner; A Carr; J M Leonard; L M Lehman; F Gudiol; J Gonzales; A Raventos; R Rubio; E Bouza; V Pintado
Journal:  N Engl J Med       Date:  1995-12-07       Impact factor: 91.245

9.  A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). The SUPPORT Principal Investigators.

Authors: 
Journal:  JAMA       Date:  1995 Nov 22-29       Impact factor: 56.272

10.  Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group.

Authors:  A C Collier; R W Coombs; D A Schoenfeld; R L Bassett; J Timpone; A Baruch; M Jones; K Facey; C Whitacre; V J McAuliffe; H M Friedman; T C Merigan; R C Reichman; C Hooper; L Corey
Journal:  N Engl J Med       Date:  1996-04-18       Impact factor: 91.245
View more
  1 in total

1.  Taking antiretroviral therapy for HIV infection: learning from patients' stories.

Authors:  M B Laws; I B Wilson; D M Bowser; S E Kerr
Journal:  J Gen Intern Med       Date:  2000-12       Impact factor: 5.128
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.